Xiamen Kingway Group Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Public

  • Employees
  • 2,184

Employees

  • Stock Symbol
  • 002626

Stock Symbol

  • Investments
  • 10

  • Share Price
  • $2.54
  • (As of Friday Closing)

Xiamen Kingway Group General Information

Description

Xiamen Kingdomway Group Co is engaged in Production and sales of raw materials for the food fortification industry and finished health food products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Number 299, Yangguang West Road
  • Haicang District
  • Xiamen, Fujian 361022
  • China
+86 0592
Primary Industry
Other Consumer Non-Durables
Stock Exchange
SHE
Corporate Office
  • Number 299, Yangguang West Road
  • Haicang District
  • Xiamen, Fujian 361022
  • China
+86 0592

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Xiamen Kingway Group Stock Performance

As of 13-Nov-2026, Xiamen Kingway Group’s stock price is $2.54. Its current market cap is $1.55B with 610M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.54 $2.52 $1.90 - $2.99 $1.55B 610M 8.76M $0.06

Xiamen Kingway Group Financials Summary

As of 30-Sep-2026, Xiamen Kingway Group has a trailing 12-month revenue of $493M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 1,549,192 1,710,687 1,288,510 1,413,214
Revenue 492,874 467,977 451,547 438,535
EBITDA 45,650 81,790 93,956 79,616
Net Income 33,783 47,266 47,661 39,112
Total Assets 1,084,732 1,102,547 875,618 755,211
Total Debt 355,211 356,823 190,017 126,130
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Xiamen Kingway Group Patents

Xiamen Kingway Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260184746-A1 Sweet protein mutants, preparation methods, and use thereof Pending 31-Dec-2024
US-20260184747-A1 Sweet protein mutants, preparation methods, and use thereof Inactive 31-Dec-2024
US-20250367230-A1 Method for preparing same microcapsules Pending 28-May-2024
US-20250312286-A1 Method for preparing microcapsule, microcapsule and composition containing the same Pending 07-Apr-2024
US-12221645-B2 Processes for producing reduced coenzyme q10 Active 25-May-2023 C12P7/66
To view Xiamen Kingway Group’s complete patent history, request access »

Xiamen Kingway Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Xiamen Kingway Group Investments & Acquisitions (10)

Xiamen Kingway Group’s most recent deal was a Later Stage VC with Beijing Huaguan Biotechnology. The deal was made on 19-Aug-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Beijing Huaguan Biotechnology 19-Aug-2021 Later Stage VC Drug Discovery
Chengxin Pharmaceutical 07-Dec-2020 Merger/Acquisition Specialty Chemicals
Joy Pony 01-Jul-2020 Early Stage VC Educational and Training Services (B2C)
Zipfizz 01-Aug-2018 Merger/Acquisition Beverages
ProSupps 01-Aug-2016 Merger/Acquisition Other Consumer Non-Durables
You’re viewing 5 of 10 investments and acquisitions. Get the full list »

Xiamen Kingway Group ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

40.9 | Severe Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,585

Rank

Percentile

Pharmaceuticals

Industry

of 852

Rank

Percentile

Pharmaceuticals

Subindustry

of 354

Rank

Percentile

To view Xiamen Kingway Group’s complete esg history, request access »

Xiamen Kingway Group Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
ProSupps Plano, TX 2012
Chengxin Pharmaceutical Nantong, China 2010
Zipfizz Woodinville, WA 2003
Doctor's Best Tustin, CA 1990

Xiamen Kingway Group FAQs

  • When was Xiamen Kingway Group founded?

    Xiamen Kingway Group was founded in 1997.

  • Where is Xiamen Kingway Group headquartered?

    Xiamen Kingway Group is headquartered in Xiamen, China.

  • What is the size of Xiamen Kingway Group?

    Xiamen Kingway Group has 2,184 total employees.

  • What industry is Xiamen Kingway Group in?

    Xiamen Kingway Group’s primary industry is Other Consumer Non-Durables.

  • Is Xiamen Kingway Group a private or public company?

    Xiamen Kingway Group is a Public company.

  • What is Xiamen Kingway Group’s stock symbol?

    The ticker symbol for Xiamen Kingway Group is 002626.

  • What is the current stock price of Xiamen Kingway Group?

    As of 13-Nov-2026 the stock price of Xiamen Kingway Group is $2.54.

  • What is the current market cap of Xiamen Kingway Group?

    The current market capitalization of Xiamen Kingway Group is $1.55B.

  • What is Xiamen Kingway Group’s current revenue?

    The trailing twelve month revenue for Xiamen Kingway Group is $493M.

  • What is Xiamen Kingway Group’s annual earnings per share (EPS)?

    Xiamen Kingway Group’s EPS for 12 months was $0.06.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process